Graham Capital Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $406K | Sell |
12,848
-3,467
| -21% | -$110K | 0.01% | 860 |
|
|
2025
Q1 | $541K | Buy |
16,315
+1,625
| +11% | +$53.9K | 0.01% | 741 |
|
|
2024
Q4 | $505K | Buy |
+14,690
| New | +$505K | 0.01% | 706 |
|
|
2024
Q3 | – | Sell |
-10,523
| Closed | -$317K | – | 1160 |
|
|
2024
Q2 | $317K | Sell |
10,523
-15,241
| -59% | -$460K | 0.01% | 688 |
|
|
2024
Q1 | $865K | Buy |
+25,764
| New | +$865K | 0.02% | 442 |
|
|
2023
Q3 | – | Sell |
-14,585
| Closed | -$513K | – | 1124 |
|
|
2023
Q2 | $513K | Sell |
14,585
-103,548
| -88% | -$3.64M | 0.01% | 538 |
|
|
2023
Q1 | $3.86M | Buy |
118,133
+85,405
| +261% | +$2.79M | 0.12% | 111 |
|
|
2022
Q4 | $1.8M | Buy |
32,728
+15,529
| +90% | +$856K | 0.05% | 310 |
|
|
2022
Q3 | $761K | Buy |
+17,199
| New | +$761K | 0.03% | 590 |
|
|
2022
Q2 | – | Sell |
-6,166
| Closed | -$299K | – | 1113 |
|
|
2022
Q1 | $299K | Buy |
+6,166
| New | +$299K | 0.01% | 725 |
|